Clinical Trials Browser

Phase 2 × Carcinoma, Ovarian Epithelial × Pharmaceutical Preparations × Clear all

NCT06690775 2025-12-23

CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

Phase 2 Recruiting

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms